SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001214659-24-017880
Filing Date
2024-10-24
Accepted
2024-10-24 08:57:01
Documents
8

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 18 z1023242sc13da18.htm SC 13D/A 54614
2 EXHIBIT 26 ex26.htm EX-99 14315
3 GRAPHIC ex26-001.jpg GRAPHIC 114238
4 GRAPHIC ex26-002.jpg GRAPHIC 147280
5 GRAPHIC ex26-003.jpg GRAPHIC 154285
6 GRAPHIC ex26-004.jpg GRAPHIC 148560
7 GRAPHIC ex26-005.jpg GRAPHIC 142372
8 GRAPHIC ex26-006.jpg GRAPHIC 47667
  Complete submission text file 0001214659-24-017880.txt   1110230
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Subject) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-86428 | Film No.: 241390858
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8581 SANTA MONICA BLVD LOS ANGELES CA 90069
Business Address
William Anderson Wittekind (Filed by) CIK: 0001753085 (see all company filings)

Type: SC 13D/A